Innovative health technologies: Point & Click for Nip n TuckDr Mariann Hardey
This presentation is part of a research symposium, held in Barcelona, seeking to understand how, for whom and to what extent changes in the material conditions of health information and communication is transforming a generation of medical knowledge, the conception of health and the demand and provision of healthcare delivery.
Presentation by Stéphane Heymans, Doctors of the World, on the occasion of the EESC hearing on Better Roma inclusion through civil society initiatives: focus on health and anti-discrimination (Brussels, 12 May 2014)
EUPATI’s framework on Informing the “health-interested” public about medicine...Nowgen
"EUPATI's framework on Informing the “health-interested” public objectively and comprehensively about medicines R&D", presented by Jan Geissler at the EUPATI 2014 Workshop in Warsaw
This presentation gives an overview on activities and responsibilities of Dutch Cancer Society, KWF Kankerbestrijding. It was shown during the promotional activities of the organisation.
Workshop 6 - Brainstorming
& Policy Development session:
Training, information and education of MDs
"Case study: Italian Training for MDs,"
Renza Galluppi, UNIAMO, Italy
Presentation by Lilana Keith (Platform for International Cooperation on Undocumented Migrants (PICUM)) on the occasion of the EESC hearing on Better Roma inclusion through civil society initiatives: focus on health and anti-discrimination (Brussels, 12 May 2014)
Innovative health technologies: Point & Click for Nip n TuckDr Mariann Hardey
This presentation is part of a research symposium, held in Barcelona, seeking to understand how, for whom and to what extent changes in the material conditions of health information and communication is transforming a generation of medical knowledge, the conception of health and the demand and provision of healthcare delivery.
Presentation by Stéphane Heymans, Doctors of the World, on the occasion of the EESC hearing on Better Roma inclusion through civil society initiatives: focus on health and anti-discrimination (Brussels, 12 May 2014)
EUPATI’s framework on Informing the “health-interested” public about medicine...Nowgen
"EUPATI's framework on Informing the “health-interested” public objectively and comprehensively about medicines R&D", presented by Jan Geissler at the EUPATI 2014 Workshop in Warsaw
This presentation gives an overview on activities and responsibilities of Dutch Cancer Society, KWF Kankerbestrijding. It was shown during the promotional activities of the organisation.
Workshop 6 - Brainstorming
& Policy Development session:
Training, information and education of MDs
"Case study: Italian Training for MDs,"
Renza Galluppi, UNIAMO, Italy
Presentation by Lilana Keith (Platform for International Cooperation on Undocumented Migrants (PICUM)) on the occasion of the EESC hearing on Better Roma inclusion through civil society initiatives: focus on health and anti-discrimination (Brussels, 12 May 2014)
Workshop 5 - Brainstorming & Policy Development session: Social Aspects
"Presentation of Social Challenges of RD patients
in the Joint Action on Rare Diseases"
Dorica Dan, Romanian National Alliance
Patient empowerment at EU level - Katja Neubauer, Deputy Head of Unit, Healthcare Systems Unit, DG Sanco for the 8th European Patients' Rights Day in Brussels, May 12th 2014
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internetpatvocates
"How Patient (Advocates) discuss Clinical Research on the Internet", presented by Jan Geissler (Twitter @jangeissler) at DIA Clinical Forum in The Hague on 9 Oct 2012.
Workshop 7 - Brainstorming & Policy Development session: Prevention
"Presentation of the International Federation for Spina
Bifida and Hydrocephalus’ primary prevention study"
Pierre Mertens, International Federation for Spina Bifida and Hydrocephalus (IF)
Symposium presentation at 2017 annual convention of the Philippine Society of Endocrinology, Diabetes & Metabolism. 23 March 2017, EDSA Shangrila Hotel.
The rise of online fake news on social media highlights an increasing problem. This talk, given at University of Michigan, explores why health professionals have a professional obligation to ensure patients get accurate, understandable health information.
From disease-centered to patient-centered communication in breast cancerKathi Apostolidis
Breast cancer patient perspectives and experiences in patient-doctor communication
Are physicians educated and skilled to communicate difficult diagnoses to cancer patients?
What is patient centered communication?
How doctors think
Workshop 5 - Brainstorming & Policy Development session: Social Aspects
"Presentation of Social Challenges of RD patients
in the Joint Action on Rare Diseases"
Dorica Dan, Romanian National Alliance
Patient empowerment at EU level - Katja Neubauer, Deputy Head of Unit, Healthcare Systems Unit, DG Sanco for the 8th European Patients' Rights Day in Brussels, May 12th 2014
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internetpatvocates
"How Patient (Advocates) discuss Clinical Research on the Internet", presented by Jan Geissler (Twitter @jangeissler) at DIA Clinical Forum in The Hague on 9 Oct 2012.
Workshop 7 - Brainstorming & Policy Development session: Prevention
"Presentation of the International Federation for Spina
Bifida and Hydrocephalus’ primary prevention study"
Pierre Mertens, International Federation for Spina Bifida and Hydrocephalus (IF)
Symposium presentation at 2017 annual convention of the Philippine Society of Endocrinology, Diabetes & Metabolism. 23 March 2017, EDSA Shangrila Hotel.
The rise of online fake news on social media highlights an increasing problem. This talk, given at University of Michigan, explores why health professionals have a professional obligation to ensure patients get accurate, understandable health information.
From disease-centered to patient-centered communication in breast cancerKathi Apostolidis
Breast cancer patient perspectives and experiences in patient-doctor communication
Are physicians educated and skilled to communicate difficult diagnoses to cancer patients?
What is patient centered communication?
How doctors think
mhealth in cancer supportive care - how eSMART can improve quality of lifeKathi Apostolidis
several mhealth apps already in cancer care but lots need still to be done-patients want safely accessible, transferable data everywhere-eSMART project using ASyMS promises to improve the quality of life of cancer patients undergoing chemotherapy- mhealth conference at Bocconi University - Milan
How Effective is the Public in Influencing HTA Decisions?Kathi Apostolidis
Patients should be involved in HTA process to assure a robust process that embraces patients' needs, preferences, perspectives. ECPC-European Cancer Patient Coalition leverages on European Institutions for a solution to the timely authorization and reimbursement of innovative cancer medicines
The patient voice: turning health policy into opportunity - Jan Geissler - ES...patvocates
Presentation on how the patient voice can turn health policy into advocacy opportunities to improve the life of patients. Presented by Jan Geissler, Co-founder of CML Advocates Network, at the Patient Seminar of the European Society of Gynaecological Oncology (ESGO) in Liverpool on 19 Sept 2013
Why Humanities & Art are important in medical educationKathi Apostolidis
Medicine graduates have to deal with complex human feelings and situations besides complex medical problems. Philosophy, humanities and art will help students to link medicine to its human dimension
The ESMO-ECPC Cancer Survivorship Guide and Cancer Survivorship Plan is a unique care and cancer advocacy tool.
Cancer patient advocates can include it in their work.
Μπορεί η Ελλάδα να συνεχίσει να μην έχει εθνική πολιτική και τα απαραίτητα γι αυτό εργαλεία; Είναι άμεση ανάγκη να αποκτήσει η Ελλάδα το συντομότερο Εθνικό Σχέδιο Δράσης για τον έλεγχο του Καρκίνου και πληθυσμιακό Εθνικό Μητρώο Νεοπλασιών. Η Ευρωπαϊκή Κοινή Δράση για τον Ελεγχο του Καρκίνου (CANCON) αποτέλεσμα της συνεργασίας 17 χωρών μελών, 26 Ευρωπαϊκών επιστημονικών φορέων και οργανώσεων, 66 λοιπών εταίρων μεταξύ τών οποίων πανεπιστήμια, ογκολογικά ινστιτούτα, κέντρα ερευνών, Ευρωπαϊκές οργανώσεις ασθενών, φαρμακευτικές εταιρείες, επιστημονικές ιατρικές εταιρείες, προϊόν της εθελοντικής συνεργασίας της Ευρωπαϊκής ογκολογικής κοινότητας είναι ο οδηγός για την άριστη παροχή ογκολογικής περίθαλψης αλλά και για την κατάρτιση σύγχρονου Εθνικού Σχεδίου Δράσης
Is there patient involvement in HTA? Can patients influence HTA decision making?Kathi Apostolidis
Is HTA purely technical?
drivers for patient involvement in HTA
patient participation or tokenism
medicines do not reach patients due to delays in HTA evaluation
need for harmonized HTA
The Role of Patients & their Challenges in Clinical TrialsKathi Apostolidis
What are clinical trials
Myths about clinical trials
What patients want
The role of patients in clinical trials
How to communicate trial information
How to communicate trial results
The cross-border that became a European law in 2013 has many valuable provisions but its implementation seems almost impossible due the complex European health care reimbursement systems, lack of information for patients, delay in establishing Eur. Reference Centers,
H σχέση & η επικοινωνία με την ιατρική ομάδα από τη πλευρά του ογκολογικού ασ...Kathi Apostolidis
Τι περιμένει ο ογκολογικός ασθενής από την επικοινωνία με την ιατρική ομάδα που έχει αναλάβει τη περίθαλψή του;
Η σημασία της αφήγησης της ασθένειας για το γιατρό
I know and exercise my patient rights when I am ill-Γνωρίζω τα Δικαιώματά μου...Kathi Apostolidis
A presentation on the content of the Greek patient rights legislation and how patients can make use of it-Παρουσίαση για την νομοθεσία για τα δικαιώματα των ασθενών και πως μπορούν να τα ασκήσουν
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
2. ECPC-European Cancer Patient Coalition
• Established in 2003
• Only European organization governed by
cancer patient groups
• 340 members in 44 countries
• All age groups, ethnic communities,
cancer types
• Full members European patient groups
governed by patients, for patients
3. European Cancer Patient Coalition
Mission
Equip, Enable, Engage & Empower our
members to
• actively advocate for equality in access
to front line cancer care and
• to engage in all aspects of cancer care,
treatment and research locally, nationally
and internationally
“Nothing about us without us”
4. • Hospitals, surgeries designed to meet
needs of people working in them, finances
of governments paying for them
• Healthcare policies dictated by medical
profession, politicians, health industry
• Health technology, medicines, research
conducted by technicians, scientists alone
Where is the patient?
European Cancer Patient Coalition
How is healthcare designed?
5. Where is the patient?
• The “new” patient is online! & in online/offline
communities
• He searches for information about his disease,
new therapies,
• He discusses about his preferences with his
doctors
• He seeks to contact peer patients
• Exchanges information
The “new” patient wants to meaningfully
participate in his care!
6. What does “healthcare” know
about the new breed of patients?
Men Elderly
Women
Families
Ethnic
groups migrants
Youth
Children
7. Who were the most acclaimed speakers
at the Quality of Care Conf. in Chania,
Crete last Friday?
European Cancer Patient Coalition
Margaret Murphy: Patients for Patient
Safety, World Health Organization
(WHO) World Alliance for Patient Safety
Chair – RA Patients
Association of Crete
Marina Tzanakis-
Chair-EFZO me ton
Karkino-Cancer
Patient Association
Crete
8. Why did audience gathered on Saturday
in Hall5.1. at ECCO in Amsterdam?
European Cancer Patient Coalition
9. Patient-designed healthcare?
European Cancer Patient Coalition
• CML AdvocatesNetwork @cmlnet 28 Sep
Adherence strongly influenced by doctor-patient relationship: well-
informed patients & approachable doctors drive adherence
#ECC2013 #ECCH5
12. Patient-designed healthcare?
CHAORDIC: What if your data did not
have to die in dusty paper files and
unconnected electronic silos? What if
many private institutions, non-profit
organizations, research centers,
government entities and individual
patients decided to share data? What if
we could do this over a span of years
creating an ever larger data set? That
data set could be accessed by the many
in a timely fashion that will enable both
the individual and the organization to
make informed health decisions.
13. Patient-designed healthcare:
the new reality
• Informed Shared Medical Decision Making
• Quality of Care
• Patient empowerment to understand his
disease, his treatment & care & to speak
about his preferences
• Respect of patient dignity & preferences
• Patient involvement in healthcare policy
planning, design of research, medicines
development, evaluation of health care
providers
14. Thank you for your attention!
Kathi Apostolidis – Vice President
ECPC/Belgium
Chair –Intergroup Committee for Cancer
Patient Rights Advocacy /Greece
Board Member –KEFI – Cancer Patients,
Doctors & Friends Association/Greece
Twitter: @kgapo, @cancereu, #opnhealth
YouTube: ECPCTV
Facebook: European Cancer Patient Coal.ition,
#opnhealth
Wordpress: http://epatientgr.wordpress.com
Pinterest: Kathi Apostolidis
CREDITS: Art Work from Regina Holliday's Medical Advocacy Blog
A place where art, medicine, social media and pop-culture collide and create a
patient voice in health information technology.